European Journal of Cancer
Volume 37, Issue 3 , Pages 369-375 , February 2001

Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma

  • A. Lafuma

      Affiliations

    • Cemka, 43 boulevard du Maréchal Joffre, F-92340, Bourg-la-Reine, France
    • Corresponding Author InformationCorresponding author. Tel.: +33-1-4091-3030; fax: +33-1-4091-3031
    • ,
  • B. Dreno

      Affiliations

    • CHR Hôtel-Dieu, Nantes, France
    • ,
  • M. Delaunay

      Affiliations

    • Hôpital Pellegrin, Bordeaux, France
    • ,
  • C. Emery

      Affiliations

    • Cemka, 43 boulevard du Maréchal Joffre, F-92340, Bourg-la-Reine, France
    • ,
  • F. Fagnani

      Affiliations

    • Cemka, 43 boulevard du Maréchal Joffre, F-92340, Bourg-la-Reine, France
    • ,
  • K. Hieke

      Affiliations

    • Roche Pharmaceuticals, Switzerland
    • ,
  • J.-J. Bonerandi

      Affiliations

    • Hôpital Sainte-Marguerite, Marseille, France
    • ,
  • J.-J. Grob

      Affiliations

    • Hôpital Sainte-Marguerite, Marseille, France
    • ,
  • for the French Cooperative Group on Melanoma

      Affiliations

Received 10 April 2000 ,Revised 28 September 2000 ,Accepted 12 November 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(00)00411-1

European Journal of Cancer
Volume 37, Issue 3 , Pages 369-375 , February 2001

Article Tools

* Image Usage & Resolution